Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) on 2016-08-08 announced an EPS of $-0.31. Estimates for the company’s EPS stand at $-0.22. A week ago the earnings estimates stood at $-0.22 changing by 0%, while a month ago they were $-0.22.
The company had received an EPS estimate of $-0.22 60 days ago while 90 days ago the estimates were at $-0.22.
In the last 7 days the company has seen 2 upward revisions in its EPS estimates while the number of downward revisions was EPS_CNT_EST_REV_DOWN_LAST_7D:1835}}. Similarly, its EPS estimates were increased 2, 2, 2 and 2 times in the last 30, 60, 90 and 120 days respectively.
In the last 120, 90, 60 and 30 days periods the EP estimates were downgraded 2, 2, 2, 2 times.
In the previous 18 days the estimates saw upward revision 2 times and downward revision 2 times.
From a total of 2 estimates, the company’s mean EPS estimate for the period ended 2 stood at $-0.22. As such the difference amount from the actual EPS was $-0.09, which comes to -40.91%. Right before the announcement of the actual EPS, the estimates ha d a standard deviation of 0.06.
Coming to sales figures, Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) is estimated to register annual sales of $6.3. The figure is the arithmetic mean of all estimates by 2 analysts while the median comes to $6.3 for the fiscal year 2016.
The highest estimate stands at $9.6 while lowest is $3. The annual sales estimate have a standard deviation of 4.666%.
In the last week 2 analysts increased their sales estimates while 2 decreased their estimates. The mean estimate changed by 0% from last week.
Over the last month, 2 analysts revised their estimates upwards while 2 analysts revised their estimates downwards. The mean estimate saw a change of 32.631% from a month ago.
Over the last 3 month period, 2 analysts revised their sales estimates for Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) upwards while 2 analysts downgraded their estimates. The mean estimate from 3 months ago underwent a change of 32.631%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...